Details
Stereochemistry | ACHIRAL |
Molecular Formula | As4S4 |
Molecular Weight | 427.946 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
S1[As]2S[As]3S[As]2S[As]13
InChI
InChIKey=XPDICGYEJXYUDW-UHFFFAOYSA-N
InChI=1S/As4S4/c5-1-2-7-3(5)4(6-1)8-2
Molecular Formula | As4S4 |
Molecular Weight | 427.946 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tetraarsenic Tetrasulfide (also known as Realgar, "ruby sulfur" or "ruby of arsenic") is an arsenic compound with antitumor activity, especially in acute promyelocytic leukemia that is resistant to retinoic acid. Tetraarsenic Tetrasulfide is a soft, sectile mineral occurring in monoclinic crystals, or in granular, compact, or powdery form, often in association with the related mineral, orpiment. Tetraarsenic Tetrasulfide is in wide use in traditional Chinese medicine. Early clinical exploration of Tetraarsenic Tetrasulfide for the treatment of AML and CML started in the 1960s and suggested that Tetraarsenic Tetrasulfide was a potent agent for leukemia treatment. Recently, a single-center pilot study demonstrated that Tetraarsenic Tetrasulfide treatment was effective and convenient for treating low-risk acute promyelocytic leukemia patients. Based on these clinical achievements, Tetraarsenic Tetrasulfide has been approved by the China Food and Drug Administration and recommended as a second-line chemotherapeutic agent for the treatment of acute promyelocytic leukemia in China
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00517712
Adults: 10 mg once a day Children or adults <45kg: 0.15 mg/kg/day (maximum dose = 10mg) once a day
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:26:56 UTC 2023
by
admin
on
Fri Dec 15 17:26:56 UTC 2023
|
Record UNII |
ZIK02R2PSD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
12044-79-0
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
ALTERNATIVE | |||
|
C058317
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
m2060
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | Merck Index | ||
|
C534735
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
DTXSID50153717
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
139298
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
ZIK02R2PSD
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
1426938
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | RxNorm | ||
|
ZIK02R2PSD
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
300000023294
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY | |||
|
12279-90-2
Created by
admin on Fri Dec 15 17:26:56 UTC 2023 , Edited by admin on Fri Dec 15 17:26:56 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |